T. Rowe Price Associates’s InflaRx IFRX Stock Holding History

T. Rowe Price Associates’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-77,547	Closed	-$2.93M	–	2551
2019 Q1	$2.93M	Buy	+77,547	New	+$2.89M	﹤0.01%	1489

Other funds holding IFRX

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return

T. Rowe Price Associates's IFRX Position: Q2 2019 in Review

T. Rowe Price Associates sold out of InflaRx (IFRX) in Q2 2019, closing a stake of 77,547 shares — an estimated $2.93M sold.

T. Rowe Price Associates first reported a position in IFRX in Q1 2019 and held it in 1 quarter. The position peaked at $2.93M in Q1 2019. 28 funds tracked by Wall St. Rank hold IFRX as of Q2 2019.

T. Rowe Price Associates reported no remaining InflaRx position as of Q2 2019 after selling out during the quarter.
T. Rowe Price Associates sold 77,547 InflaRx shares in Q2 2019, an estimated $2.93M.
T. Rowe Price Associates first reported a position in InflaRx in Q1 2019 and held it in 1 quarter.
T. Rowe Price Associates's InflaRx position peaked at $2.93M in Q1 2019.
28 funds tracked by Wall St. Rank held InflaRx as of Q2 2019.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.